SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC - MADRIGAL PHARMACEUTICALS INC ownership

MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 228 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.28 and the average weighting 0.4%.

Quarter-by-quarter ownership
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC ownership history of MADRIGAL PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$727,657
+6.2%
2,507
-64.1%
0.01%0.0%
Q1 2022$685,000
-23.7%
6,985
-34.1%
0.01%
-45.8%
Q4 2021$898,000
+30.3%
10,603
+22.7%
0.02%
+84.6%
Q3 2021$689,000
+184.7%
8,641
+317.8%
0.01%
+225.0%
Q1 2021$242,0002,0680.00%
Other shareholders
MADRIGAL PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
PACIFIC VIEW ASSET MANAGEMENT, LLC 25,070$2,825,0003.32%
HealthCor Management, L.P. 688,890$77,652,0002.43%
Avoro Capital Advisors LLC 225,000$25,362,0001.52%
EMORY UNIVERSITY 17,038$1,921,0001.51%
Rock Springs Capital Management LP 241,000$27,166,0001.28%
Baker Brothers Advisors 1,169,278$131,801,0001.08%
Caption Management, LLC 100,800$11,362,0000.91%
SHIKIAR ASSET MANAGEMENT INC 14,341$1,617,0000.84%
Pier Capital, LLC 37,654$4,244,0000.84%
Atika Capital Management LLC 20,000$2,254,0000.66%
View complete list of MADRIGAL PHARMACEUTICALS INC shareholders